Roche CT-388 Obesity Drug shows up to 22.5% placebo-adjusted weight loss at 48 weeks, as Roche moves into Phase 3 to challenge Lilly and Novo.
You must be a subscriber to access all of this content.
AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.
You must be a subscriber to access all of this content.
South Africa faces an HIV ARV tender crisis as major suppliers enter business rescue, risking vital medicine availability.
You must be a subscriber to access all of this content.
WhatsApp Microlearning helps clinics deliver quick, practical HIV policy updates, improving guideline uptake and service delivery.
You must be a subscriber to access all of this content.
Gauteng Health Budget Underspending could return R463.5m to the fiscus, despite crumbling hospitals, vacancies and equipment shortages.
You must be a subscriber to access all of this content.
Business Unity South Africa (Busa) has backed Finance Minister Enoch Godongwana’s call to cool tensions around National Health Insurance.
You must be a subscriber to access all of this content.